Businesses face wide-ranging issues as the world
responds to the COVID 19 pandemic. Here is the latest guidance from
Torys.
Businesses are stepping in to help the global fight against the
pandemic. Life sciences companies are manufacturing and
distributing urgently needed personal protective equipment for
frontline workers, and medical devices such as test kits and
respirators.
Health Canada has in turn taken steps to expediate approvals of
these products, even where they may not meet current regulatory
requirements. However, unlike in the United States, Canada has not
adopted measures to limit potential claims that may arise from
their distribution and sale.
In our latest
guidance we consider the scope of protection available to life
sciences companies in this context, and steps they can take to
mitigate their exposure to potential future third-party claims.
